SLONIN JONATHAN (CIK 1875723) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-05). Recent activity: Sell PCRX (4,728 shares), Sell PCRX (3,261 shares), Buy PCRX (54,546 shares), Sell PCRX (6,168 shares), Sell PCRX (381 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-05 | Pacira BioSciences, Inc. (PCRX) | Chief Medical Officer | Sell | 4,728 | $105,529 |
| 2026-03-19 | Pacira BioSciences, Inc. (PCRX) | Chief Medical Officer | Sell | 3,261 | $74,416 |
| 2026-02-13 | Pacira BioSciences, Inc. (PCRX) | Chief Medical Officer | Buy | 54,546 | $0 |
| 2026-02-03 | Pacira BioSciences, Inc. (PCRX) | Chief Medical Officer | Sell | 6,168 | $126,691 |
| 2026-01-06 | Pacira BioSciences, Inc. (PCRX) | Chief Medical Officer | Sell | 381 | $9,319 |
| 2025-11-19 | Pacira BioSciences, Inc. (PCRX) | Chief Medical Officer | Sell | 3,960 | $95,396 |
| 2025-08-04 | Pacira BioSciences, Inc. (PCRX) | Chief Medical Officer | Sell | 315 | $6,952 |
| 2025-06-05 | Pacira BioSciences, Inc. (PCRX) | Chief Medical Officer | Sell | 5,084 | $134,218 |
| 2025-02-04 | Pacira BioSciences, Inc. (PCRX) | Chief Medical Officer | Buy | 93,600 | $0 |
Source: SEC Form 4 filings · as of 2026-06-05